Baluarte, Janet .
HRN: 12-70-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2024
CEFUROXIME 500MG (TAB)
08/03/2024
08/09/2024
PO
500 Mg Tab
BID
Sp Ltcs
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes